Division of Nephrology, Department of Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross Society and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Artif Organs. 2012 Dec;36(12):1059-65. doi: 10.1111/j.1525-1594.2012.01508.x. Epub 2012 Aug 10.
Mid-dilution and mixed-dilution on-line hemodiafiltration (OL-HDF) techniques are innovated to overcome the limitations of two standard techniques including predilution and postdilution. Unfortunately, the head-to-head comparisons between these two novel techniques in the same study are still limited. Moreover, the original mid-dilution and mixed-dilution OL-HDF need special dialyzers and special machines. In the present study, simple mid-dilution and simple mixed-dilution OL-HDF were settled with the aim for clinical use in general hemodialysis (HD) centers. The efficacies of uremic toxins removal between both modalities were measured and compared. This prospective randomized crossover study was conducted on 12 stable HD patients undergoing simple mixed-dilution and simple mid-dilution OL-HDF techniques. HD prescriptions were similar in both techniques. The dialysis efficacies were determined by calculating small- (urea, creatinine, and phosphate) and middle-molecule (beta-2 microglobulin [β2M]) removal. Moreover, potential complications such as high transmembrane pressure (TMP) and protein loss were also observed. Simple mixed-dilution OL-HDF provided significantly greater clearances of urea, creatinine, and β2M when compared with the simple mid-dilution OL-HDF techniques. Phosphate clearances in both techniques were comparable. In addition, TMP and dialysate albumin loss were not different. There were no intradialytic complications in both techniques. Simple mixed-dilution OL-HDF could provide greater efficacy for small- and middle-molecule clearances and acceptable potential risks, while phosphate removal is comparable.
中稀释和混合稀释在线血液透析滤过(OL-HDF)技术是创新的,以克服两种标准技术,包括预稀释和后稀释的局限性。不幸的是,在同一研究中,这两种新技术之间的头对头比较仍然有限。此外,原始的中稀释和混合稀释 OL-HDF 需要特殊的透析器和特殊的机器。在本研究中,简单的中稀释和简单的混合稀释 OL-HDF 与一般血液透析(HD)中心的临床使用的目的解决。测量并比较了两种模式下尿毒症毒素清除的效果。这项前瞻性随机交叉研究在 12 名接受简单混合稀释和简单中稀释 OL-HDF 技术的稳定血液透析患者中进行。两种技术的 HD 处方相似。通过计算小分子(尿素、肌酐和磷酸盐)和中分子(β2 微球蛋白[β2M])清除率来确定透析效果。此外,还观察到潜在的并发症,如高跨膜压(TMP)和蛋白质丢失。与简单中稀释 OL-HDF 技术相比,简单混合稀释 OL-HDF 提供了显著更高的尿素、肌酐和β2M 的清除率。两种技术的磷酸盐清除率相当。此外,TMP 和透析液白蛋白损失没有差异。两种技术均无透析中并发症。简单混合稀释 OL-HDF 可以提供更大的小分子和中分子清除效果,并且具有可接受的潜在风险,而磷酸盐的清除率相当。